These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5124876)

  • 1. Urinary hydroxyproline excretion in patients with breast cancer.
    Cuschieri A; Felgate R
    Br J Surg; 1971 Nov; 58(11):862. PubMed ID: 5124876
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
    Ditzel J; Jordal R; Riskoer N
    Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
    Gasser AB; Depierre D; Alberto P; Courvoisier B
    Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Early' breast cancer, bone scanning, and the urinary excretion of hydroxyproline.
    Sumner DS; Baum M; Parsons V; Edwards MH
    Br J Surg; 1973 Apr; 60(4):306. PubMed ID: 4700234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hydroxyproline excretion as an index for the evaluation of metabolic bone changes].
    Mühlbach R
    Beitr Orthop Traumatol; 1966 Oct; 13(10):606-8. PubMed ID: 5977397
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hydroxyprolinuria in relation to bone metastases in patients with breast cancer].
    Rico Lenza H; Millán Núñez-Cortés J; Rodríguez Mora VI; Espinós Pérez D
    Rev Esp Oncol; 1980; 27(1):61-6. PubMed ID: 7209108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
    Niell HB; Palmieri GM; Neely CL; McDonald MW
    Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary hydroxyproline excretion in carcinoma of the breast.
    Cuschieri A; Felgate RA
    Br J Exp Pathol; 1972 Jun; 53(3):237-41. PubMed ID: 5055709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyproline excretion in patients with breast cancer and response to treatment.
    Powles TJ; Leese CL; Bondy PK
    Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
    Martoni A; Pedelini G; Colalongo G; Biagi R; Mambelli M; Jafelice G; Rocchetta G; Piana E; Pannuti F
    Minerva Med; 1980 Sep; 71(31):2215-9. PubMed ID: 7422143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
    Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
    Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyproline and zinc excretion in patients with neoplastic breast disease.
    Percudani M; Dell'Anna B; De Lorenzis GF; Ferraccioli GF; Vaona GL
    Int Surg; 1981; 66(3):233-6. PubMed ID: 7319736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary hydroxyproline excretion in patients with cancer.
    Guzzo CE; Pachas WN; Pinals RS; Krant MJ
    Cancer; 1969 Aug; 24(2):382-7. PubMed ID: 5796782
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary hydroxyproline in the management of breast cancer.
    Cuschieri A
    World J Surg; 1977 May; 1(3):299-302. PubMed ID: 883324
    [No Abstract]   [Full Text] [Related]  

  • 15. Early morning hydroxyproline excretion in patients with breast cancer.
    Powles TJ; Rosset G; Leese CL; Bondy PK
    Cancer; 1976 Dec; 38(6):2564-6. PubMed ID: 1000483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
    Ditzel J; Jordal R; Riskaer N
    Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Urinary hydorxyproline excretion in the monitoring of carcinoma of the breast.
    Lester E
    Br J Radiol; 1976 Mar; 49(579):290. PubMed ID: 1276611
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of urinary hydroxyproline excretion as a marker of bone metastases in prostatic cancer (1)].
    Kurokawa K; Imai K; Yamanaka H; Tomaru Y; Kitaura K
    Hinyokika Kiyo; 1985 Dec; 31(12):2119-25. PubMed ID: 2421558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of hydroxyprolinuia for the proof of bone metastases of tumours.
    Mirejovská E; Beska F; Pitronová M
    Neoplasma; 1968; 15(4):433-8. PubMed ID: 5684467
    [No Abstract]   [Full Text] [Related]  

  • 20. [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases].
    Polico C; Nascimben O; Maccari F; Fazzin G
    Quad Sclavo Diagn; 1978 Dec; 14(4):486-93. PubMed ID: 757622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.